Methylenetetrahydrofolate reductase (MTHFR) gene c.665C>T and c.1286A>C and SERPINE1 -675 4G/5G polymorphisms in Polish patients with venous thromboembolism and cryptogenic ischemic stroke

Pol Arch Intern Med. 2022 Feb 28;132(2):16218. doi: 10.20452/pamw.16218. Epub 2022 Feb 17.

Authors

Adrianna Klajmon¹, Mariusz Cichoń², Joanna Natorska^{1

3}, Anetta Undas^{1

3}, Ewa Wypasek⁴

Affiliations

¹ John Paul II Hospital, Kraków, Poland
² Institute of Environmental Sciences, Jagiellonian University, Kraków, Poland
³ Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
⁴ John Paul II Hospital, Kraków, Poland; Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland. e.wypasek@szpitaljp2.krakow.pl

PMID: 35226442
DOI: 10.20452/pamw.16218

No abstract available

MeSH terms

Humans
Ischemic Stroke* / genetics
Methylenetetrahydrofolate Reductase (NADPH2)* / genetics
Plasminogen Activator Inhibitor 1* / genetics
Poland
Polymorphism, Genetic
Venous Thromboembolism* / genetics

Substances

Plasminogen Activator Inhibitor 1
SERPINE1 protein, human
MTHFR protein, human
Methylenetetrahydrofolate Reductase (NADPH2)